=

Teva’s proposed opioid settlement could cost drugmaker pennies on the dollar

111111111

October 24, 2019 0 Comments
Teva Pharmaceutical’s proposed $23 billion drug giveaway to settle thousands of U.S. opioid lawsuits will likely cost the company a fraction of that figure due to how it has valued those medicines, according to a Reuters review.
Tags:
Share: